|
Applied Nutrition PLC on Tuesday forecast revenue will be ahead of City expectations for the financial year just ended, and predicted further growth ahead. In response, shares in the Liverpool-based sports nutrition brand rose 7.6% to 141.14 pence each in London on Tuesday morning. They hit an intraday high of 147.60p earlier. Applied Nutrition was admitted to trading on the London Stock Exchange’s Main Market last October. The initial public offering was priced at 140 pence per share. Applied Nutrition expects revenue for the financial year ending July 31 of £107 million, up 24% from £86 million in financial 2024, and ahead of market expectations for £100 million. Adjusted earnings before interest, tax, depreciation and amortisation is expected to increase 19% year-on-year from £26 million a year ago, suggesting adjusted Ebitda of more than £30 million. This was driven by strong second-half trading which contributed around £60 million of revenue, Applied Nutrition said. Net cash, excluding IFRS 16 liabilities, at the end of period also is expected to be ahead of market expectations, coming in at around £18.5 million, compared to £16.6 million consensus. In addition, Applied Nutrition expects revenue for the financial year to July 2026 to be ahead of current expectations of £112.4 million. The company said it is confident of ‘sustained revenue growth and strong profitability over the long-term’. Chief Executive Thomas Ryder said: ‘We are proud to report that we have exceeded the guidance we gave at our IPO, with our first full-year results expected to come in ahead of market expectations.’ Results for the financial year are expected to be announced on, or around, November 10. Copyright 2025 Alliance News Ltd. All Rights Reserved.
|
